NCT04858009 2025-12-16Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal MetastasisMayo ClinicPhase 2 Recruiting40 enrolled
NCT02495896 2025-11-10Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsUniversity of Southern CaliforniaPhase 1 Active not recruiting61 enrolled
NCT06423326 2025-07-30Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic CancerEmory UniversityPhase 2 Recruiting36 enrolled